EP0862407A1 - Topical formulations and delivery systems - Google Patents
Topical formulations and delivery systemsInfo
- Publication number
- EP0862407A1 EP0862407A1 EP96936055A EP96936055A EP0862407A1 EP 0862407 A1 EP0862407 A1 EP 0862407A1 EP 96936055 A EP96936055 A EP 96936055A EP 96936055 A EP96936055 A EP 96936055A EP 0862407 A1 EP0862407 A1 EP 0862407A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- formulation
- agent
- sodium lauryl
- hydrogen peroxide
- foam
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000012049 topical pharmaceutical composition Substances 0.000 title description 2
- 239000000203 mixture Substances 0.000 claims abstract description 108
- 238000009472 formulation Methods 0.000 claims abstract description 96
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 72
- 239000006260 foam Substances 0.000 claims abstract description 61
- 239000013535 sea water Substances 0.000 claims abstract description 35
- 239000013043 chemical agent Substances 0.000 claims abstract description 34
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims abstract description 31
- 239000004094 surface-active agent Substances 0.000 claims abstract description 28
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims abstract description 19
- 239000004479 aerosol dispenser Substances 0.000 claims abstract description 17
- 229940124447 delivery agent Drugs 0.000 claims abstract description 12
- 125000000129 anionic group Chemical group 0.000 claims abstract description 6
- 239000007921 spray Substances 0.000 claims description 31
- 238000000034 method Methods 0.000 claims description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 14
- 239000000243 solution Substances 0.000 claims description 8
- 235000011187 glycerol Nutrition 0.000 claims description 7
- 239000011734 sodium Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- MRTWZIXSCCETHN-UHFFFAOYSA-N 2-sulfododecanoic acid Chemical compound CCCCCCCCCCC(C(O)=O)S(O)(=O)=O MRTWZIXSCCETHN-UHFFFAOYSA-N 0.000 claims description 3
- CDOUZKKFHVEKRI-UHFFFAOYSA-N 3-bromo-n-[(prop-2-enoylamino)methyl]propanamide Chemical compound BrCCC(=O)NCNC(=O)C=C CDOUZKKFHVEKRI-UHFFFAOYSA-N 0.000 claims description 3
- 108010077895 Sarcosine Proteins 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 claims description 3
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 claims description 3
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 claims description 3
- 229940079862 sodium lauryl sarcosinate Drugs 0.000 claims description 3
- 229940075560 sodium lauryl sulfoacetate Drugs 0.000 claims description 3
- ADWNFGORSPBALY-UHFFFAOYSA-M sodium;2-[dodecyl(methyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCN(C)CC([O-])=O ADWNFGORSPBALY-UHFFFAOYSA-M 0.000 claims description 3
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 3
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims description 3
- 230000004913 activation Effects 0.000 claims description 2
- 230000000249 desinfective effect Effects 0.000 abstract description 3
- 239000003380 propellant Substances 0.000 description 26
- 239000004615 ingredient Substances 0.000 description 24
- 210000000214 mouth Anatomy 0.000 description 16
- 239000012141 concentrate Substances 0.000 description 15
- 239000000443 aerosol Substances 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000007788 liquid Substances 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 9
- 239000002537 cosmetic Substances 0.000 description 9
- 239000008367 deionised water Substances 0.000 description 9
- 229910021641 deionized water Inorganic materials 0.000 description 9
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 8
- -1 sodium alkyl sulfates Chemical class 0.000 description 8
- 239000000606 toothpaste Substances 0.000 description 8
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000003599 detergent Substances 0.000 description 7
- 239000003755 preservative agent Substances 0.000 description 7
- 230000000699 topical effect Effects 0.000 description 7
- 230000003750 conditioning effect Effects 0.000 description 6
- 239000000551 dentifrice Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000005187 foaming Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 206010052428 Wound Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 235000011399 aloe vera Nutrition 0.000 description 5
- 229940121375 antifungal agent Drugs 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 239000002324 mouth wash Substances 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 229940034610 toothpaste Drugs 0.000 description 5
- 244000144927 Aloe barbadensis Species 0.000 description 4
- 235000002961 Aloe barbadensis Nutrition 0.000 description 4
- 239000003429 antifungal agent Substances 0.000 description 4
- 239000002781 deodorant agent Substances 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 239000003906 humectant Substances 0.000 description 4
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 4
- 229960002216 methylparaben Drugs 0.000 description 4
- 235000013849 propane Nutrition 0.000 description 4
- 230000000475 sunscreen effect Effects 0.000 description 4
- 239000000516 sunscreening agent Substances 0.000 description 4
- 241000233788 Arecaceae Species 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 238000013019 agitation Methods 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 235000013844 butane Nutrition 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 3
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000001294 propane Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- 206010067152 Oral herpes Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 239000006172 buffering agent Substances 0.000 description 2
- 239000001273 butane Substances 0.000 description 2
- 230000007797 corrosion Effects 0.000 description 2
- 238000005260 corrosion Methods 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000013020 final formulation Substances 0.000 description 2
- 239000004088 foaming agent Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 230000002070 germicidal effect Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000001282 iso-butane Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229940051866 mouthwash Drugs 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N nitrogen oxide Inorganic materials O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000011045 prefiltration Methods 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 208000012260 Accidental injury Diseases 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 239000004338 Dichlorodifluoromethane Substances 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 206010018785 Gingival infections Diseases 0.000 description 1
- 208000034619 Gingival inflammation Diseases 0.000 description 1
- 208000004898 Herpes Labialis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 229940124091 Keratolytic Drugs 0.000 description 1
- 208000036232 King Evil Diseases 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 208000006595 Necrotizing Ulcerative Gingivitis Diseases 0.000 description 1
- 244000004005 Nypa fruticans Species 0.000 description 1
- 235000005305 Nypa fruticans Nutrition 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 208000007027 Oral Candidiasis Diseases 0.000 description 1
- 206010065233 Oral bacterial infection Diseases 0.000 description 1
- 229920000153 Povidone-iodine Polymers 0.000 description 1
- YUJLIIRMIAGMCQ-CIUDSAMLSA-N Ser-Leu-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YUJLIIRMIAGMCQ-CIUDSAMLSA-N 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 241000287411 Turdidae Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002386 air freshener Substances 0.000 description 1
- 125000005233 alkylalcohol group Chemical group 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 229940031012 anti-acne preparations Drugs 0.000 description 1
- 230000003602 anti-herpes Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000002141 anti-parasite Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229960005475 antiinfective agent Drugs 0.000 description 1
- 229940034982 antineoplastic agent Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 229940125687 antiparasitic agent Drugs 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 229940030999 antipsoriatics Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011280 coal tar Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229940124558 contraceptive agent Drugs 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000002788 crimping Methods 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
- 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
- 229940087091 dichlorotetrafluoroethane Drugs 0.000 description 1
- 239000003866 digestant Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004851 dishwashing Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- JZKFHQMONDVVNF-UHFFFAOYSA-N dodecyl sulfate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCOS(O)(=O)=O JZKFHQMONDVVNF-UHFFFAOYSA-N 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
- 235000021472 generally recognized as safe Nutrition 0.000 description 1
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000001530 keratinolytic effect Effects 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229940119047 mentadent Drugs 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000001272 nitrous oxide Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000008020 pharmaceutical preservative Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229960001621 povidone-iodine Drugs 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003902 salicylic acid esters Chemical class 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000000271 synthetic detergent Substances 0.000 description 1
- 238000009121 systemic therapy Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 1
- 229940029284 trichlorofluoromethane Drugs 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/22—Peroxides; Oxygen; Ozone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/965—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Definitions
- the present invention relates to topical and other hygiene formulations, and to aerosol devices useful for the delivery of such formulations in the form of lathers and foams.
- the invention relates to formulations useful in the oral cavity, such as dentifrices containing hydrogen peroxide.
- the invention relates to the pharmacological use of surfactants such as anionic surfactants, and in particular sodium lauryl sulfate.
- the invention relates to topical and other hygiene formulations containing natural sea water.
- Formulations such as cosmetics and pharmaceuticals can be dispensed in a wide variety of vehicles and forms, including powders, capsules, liquids, aerosols, and the like.
- the delivery of formulations by the aerosol route is generally considered to take one of three forms: (1) the use of "space sprays", such as spray insecticides and air fresheners, which produce very fine sprays capable of evaporating rapidly or floating in the air; (2) the use of sprays such as hair sprays and deodorants, that are intended for continuous film formation; and (3) the use of aerated foams, such as shaving creams, which are produced by the rapid expansion of a propellant through an emulsion.
- space sprays such as spray insecticides and air fresheners, which produce very fine sprays capable of evaporating rapidly or floating in the air
- sprays such as hair sprays and deodorants
- aerated foams such as shaving creams, which are produced by the rapid expansion of a propellant through an emulsion.
- Aerosols for oral and nasal therapy are generally said to incorporate medicaments as solids suspended in a propellant. More recent advances in valve and propellant technology are said to provide improved delivery to the throat and nasal areas.
- Formulations delivered in aerosol form by the use of such devices can often include the use of surfactants. For instance, surfactants are commonly used in nebulizer vehicles to decrease surface tension and thus affect particle size (Mintzer, above, p. 206).
- SLS sodium lauryl sulfate
- SLS itself was present in over 500 oral solid dosage forms approved by the FDA, as well as in 11 oral liquid dosage forms, 38 topical creams, lotions, ointments, medicates sponges or shampoos, and 28 dentrifices.
- the rinses described in both patents rely on the detersive effect of oral surfactants.
- the '708 patent describes the use of SLS as one such oral surfactant, and further describes its function as a "potentiator" for other ingredients.
- patients were instructed to use one tablespoon of various rinses.
- Such rinse products which are commercially available under the brand name "Plax" are typically swirled in the mouth in order to produce a weak foaming action.
- Natural sea water for instance, has long been thought to provide certain desirable, including healing, qualities. See, for instance, Richard Russel, A Dissertation on the use of Sea Water in the Diseases of the Glands: Particularly the Scurvy. Jaundice. King's Evil. Leprosy and the Glandular Consumption.
- Hydrogen peroxide functions as a weak antibacterial agent, a wound cleanser and a deodorant. It also serves a mechanical effect of effervescence and resultant removal of tissue and other debris.
- hydrogen peroxide When used as an oral topical, however, hydrogen peroxide is typically administered in the form of a concentrate, solution, or gel.
- the product is used for cleansing minor wounds, or minor gum inflammation resulting from dental procedures, orthodontic applications, denture irritations, accidental injury and other mouth and gum irritations (e.g., canker sores).
- Such beneficial uses of hydrogen peroxide include its use as an oral germicide, cleansing agent and hemostat. It is considered a useful disinfectant for mucous membranes because of its low toxicity. See, e.g., Zinner. D.D., et. al.; Controlled Study of the Clinical Effectiveness of A New Oxygen Gel on Plaque. Oral Debris and Gingival inflammation, Pharmacol. Ther. Dent.. October 1970,
- SLS and hydrogen peroxide have, on occasion, been used together in formulations for the oral cavity. See, for instance, U.S. Patent No. 5,104,644 and 5,174,990 (mouthrinse), 5,084,268 and 5,208,010 (tooth whitening dentifrice).
- the present invention provides a system useful for delivering chemical agent-containing formulations in the form of foams or sprays.
- the invention provides a system for delivering a chemical agent- containing formulation in the form of a foam or spray, the system comprising an aerosol dispenser containing a formulation comprising the chemical agent in the form of a solution or stable suspension and an aqueous solution of an anionic surface active agent as a delivery agent.
- the invention provides a system for delivering a foam or spray such as a disinfecting foam or spray, the system comprising an aerosol dispenser containing a deliverable (e.g., foamable or sprayable) formulation comprising lauryl sulfate, and preferably sodium lauryl sulfate, as a delivery agent.
- a deliverable e.g., foamable or sprayable
- the system is used to deliver a cleansing, antiseptic, or disinfecting foam comprising hydrogen peroxide as the active agent.
- a cleansing, antiseptic, or disinfecting foam comprising hydrogen peroxide as the active agent.
- Such a system is particularly well suited for the delivery of hydrogen peroxide to the oral cavity, i.e., as a dental or oral formulation.
- Applicant has found that the delivery of hydrogen peroxide to the oral cavity in the form of a foam or spray improves the effervescence of the formulation and, in turn, improves the removal of tissue and other debris.
- the formulation is particularly well suited to suspend and remove food particles and other debris, and then itself be rinsed away quickly. It does not appear that hydrogen peroxide has previously been effectively used for such purposes in the form of a foam or spray in the manner described herein, particularly in a manner suitable for commercial application.
- the system of the present invention is capable of producing rapid detergent action in order to instantly provide voluminous quantities of microbubbles from relatively small initial volumes of formulation.
- This detergent action greatly facilitates the effectiveness of the formulation as an oral rinse.
- the system of the present invention can rapidly provide a volume of bubbles from about 2 grams of formulation that is as great or greater than the volume obtained by swirling up to an ounce (e.g., about 25-30 grams) of a product like Plax in the mouth for 30 seconds, as recommended by the manufacturer.
- Formulations of the present invention having hydrogen peroxide have also been found to be particularly effective antifungal agents. To the best of
- hydrogen peroxide has not heretofore been approved or applied as an antifungal agent, and particularly not in the form of a foam or spray, or a composition delivered by an aerosol dispenser.
- the present invention provides a method of delivering a formulation in the form of a organoleptically acceptable foam or spray, the preferred method comprising the steps of: (1) providing a formulation comprising a chemical agent to be delivered and sodium lauryl sulfate as a delivery agent, within an aerosol dispenser, and (2) delivering the formulation in the form of a foam or spray by activation of the dispenser.
- the invention provides purified sea water compositions suitable for use in preparing formulations described herein. It appears that sea water has not heretofore been prepared in a form suitable for use in commercial cosmetic formulations.
- the present invention provides a system for delivering a wide variety of chemical agents in the form of an efficacious foam.
- chemical agents in the form of an efficacious foam.
- the following words and terms shall have the meanings ascribed to them:
- system will refer to an aerosol dispenser containing a formulation
- formulation will refer to a solution, e.g., as a single phase liquid or stable dispersion, which is capable of being delivered from an aerosol dispenser in the form of a foam or spray;
- chemical agent in turn, will refer to the active agent or other agent to be delivered in the form of a foam
- “foam”, and inflections thereof, when used as a verb shall refer to the ability of a formulation to form a foam when dispensed from an aerosol dispenser, and when used as a noun shall mean a liquid-film matrix with a mass of gas bubbles in it;
- “spray”, and inflections thereof, when used as a verb shall refer to the ability of a formulation to form a spray when dispensed from an aerosol dispenser, and when used as a noun shall mean a liquid moving in a mass of dispersed droplets, e.g., a fine jet of liquid discharged from a pressurized container, "delivery agent” shall refer to one or more ingredients in a formulation that functions to cause or facilitate either the foaming or spraying of the formulation when dispensed from an aerosol dispenser; and
- dental formulation shall refer to any formulation useful in or on the mouth or gums (such as dentifrice, mouthwash, gargle, dental liquid), or other nasopharyngeal application.
- Preferred foams of the present invention are substantially stable, yet can be readily broken upon agitation.
- the foam is substantially stable after it is formed, so long as it is not agitated.
- An example of such a foam is one that can be dispensed into the palm of the hand and there remain for at least 30 seconds, and preferably for on the order of minutes, without collapsing. Once agitated however, for instance by rubbing the palms together, the foam is readily broken and in fact essentially disappears within a second or two.
- Preferred foams are similar in appearance and consistency to the suds obtained by the agitation of dishwashing liquids, that is, they are comprised of small bubbles.
- Dispensers suitable for use in the system of the present invention are typically those that are capable of creating and dispensing a formulation in the form of a foam or spray in an aerosol manner through the use of a relatively low boiling liquid propellant such as butane and propane.
- aerosol will refer herein to the delivery of a foam or spray in a manner that employs a hydrocarbon or other suitable propellant, as further explained herein.
- Aerosol dispensers are distinct from “propellantless” dispensers, the latter type being narrowly defined as those that avoid the use of a pressurized gas to achieve rapid expansion of a propellant through an emulsion.
- Propellantless dispensers are those that rely on the use of compressed air, for instance obtained by squeezing a bottle, as opposed to piston-type or spring-loaded dispensers.
- a system of the present invention further comprises a dispenser, i.e., a container useful for holding one or more propellants, a valve, and an actuator.
- a dispenser i.e., a container useful for holding one or more propellants, a valve, and an actuator.
- Suitable aerosol dispensers provide an optimal combination of such properties as ease of use, capacity, inertness, safety and cost.
- suitable dispensers include those prepared of glass, plastic, metal or a combination of such materials. Glass containers must be carefully selected to provide an optimal level of pressure safety and impact resistance. Plastics may be employed to coat glass containers for improved safety, or to coat metal containers to improve corrosion resistance and enhance formulation stability.
- the propellant supplies the necessary pressure within an aerosol system to expel the formulation from the container and, in combination with other components, to convert the formulation into the desired foam.
- Propellants may be broadly classified as liquified or compressed gases having vapor pressures generally exceeding atmospheric.
- Propellants within this definition include various hydrocarbons, especially fluoro-chloro- derivatives of methane and ethane, low molecular weight hydrocarbons such as the propanes, butanes and pentanes, and compressed gases such as carbon dioxide, nitrogen and nitrous oxide.
- Preferred propellants suitable for use in the system of the present invention provide an optimal combination of such properties as compatibility and cost.
- preferred propellants include, but are not limited to, butane, dichlorodifluoromethane, dichlorotetrafluoroethane, isobutane, propane, trichloromonofluoromethane, and mixtures thereof.
- Suitable propellants are commercially available from a number of sources, for instance, those identified as "Aeropres 46 (A-46)", a mixture of propane and isobutane available from Aeropres Corporation, Shreveport LA.
- Aeropres 46 A-466
- the primary function of the valve is to regulate the flow of the formulation and propellant from the container.
- the characteristics of the delivered foam, including the accuracy and reproducibility of the delivery, should be optimized. Plastic, rubber, aluminum and stainless steel valves are particularly preferred.
- An actuator is a fitting attached to an aerosol valve stem which, when depressed or moved, opens the valve to permit a foam or spray to issue from the container, and directs the foam or spray containing the formulation to the desired area.
- the actuator usually indicates the direction in which the formulation is dispensed and protects the hands or fingers from the refrigerant effects of the propellant.
- Actuators can incorporate an orifice of any suitable size and shape.
- a system of the present invention comprises a delivery agent, preferably selected from the class of surface active agents known as anionic detergents.
- Suitable anionic delivery agents include sodium cocomonoglyceride sulfonate, sodium lauryl sarcosinate, sodium dodecyl benzenesulfonate, and miscellaneous other surfactants such as dioctyl sodium sulfosuccinate, sodium lauryl sulfoacetate, sulfolaurate, and the 2-hydroxyalkyl sulfates. See, e.g., "Surfactants in Oral Hygiene Products", pp. 299-347 in Surfactants in Cosmetics.
- a particularly preferred delivery agent is SLS.
- SLS is itself classified as an emulsifying, wetting, and/or solubilizing agent.
- SLS is actually a mixture of sodium alkyl sulfates, primarily sodium lauryl sulfate containing not more than a total of 8% of sodium sulfate and sodium chloride.
- SLS is a long-chain fatty alcohol sulfate, and commercially available forms of SLS involve a mixture of long-chain saturated alkyl alcohols.
- Oral grades of SLS are generally made from naturally occurring fats and oils, mostly from coconut fatty acids, or the like.
- Some products are virtually all dodecyl derivative, while others contain mixtures of dodecyl, tetradecyl, and higher derivatives, depending on the degree of fractionation of the original fatty acids.
- Such surface active agents including SLS, are preferably present in the formulation at a final concentration of between about 0.05% and about 5% , and more preferably between about 0.1 % and about 1 % , by weight, based on the weight of the chemical agent formulation.
- Formulations containing less than about 0.5% SLS tend to have poor foaming characteristics, while those containing greater than about 5% SLS tend to impart unpleasant taste or other undesirable characteristics to the formulation.
- the formulation delivered using a system of the present invention preferably comprises a chemical agent.
- Suitable chemical agents include any compound, solution or molecule that is desired to be delivered as a foam or spray to the body, including any cavity of the body.
- Examples of chemical agents that can be delivered to the body in the form of a foam or spray include topical analgesics, anesthetics, antibacterials, antibiotics, antifungal agents, anti- inflammatory agents (such as salicylates and steroids), antineoplastics, antiparasitics, antipruritics, antiviral agents, biologicals, contraceptives, dental preparations, deodorants, enzymes and digestants, germicides, hemorrhoidal preparations, hormones, minerals, vaginal preparations, and the like.
- the system of the present invention is used for the preparation of foams for the application of abradants, antiacne preparations, antibacterials and/or antifungals, antidermatitis preparations, as well as antiherpes, anti-inflammatory, antiperspiration, antipuritics, antipsoriasis, antiseborrhea, or astringent agents, coal tar, depigmenting agents, detergents, emollients, fungicides, keratolytics, moisturizers, pediculicides, photosensitizers, scabicides, skin bleaches, skin protectants, cleansers, steroids, sulfur and salicylic acid, sun screens, vesicants, wart therapeutic agents, wound dressings, and the like.
- Particularly preferred is a formulation that contains both hydrogen peroxide (as an anti-infective agent) and glycerin, aloe or other ingredient (as a skin or tissue protectant).
- hydrogen peroxide as an anti-infective agent
- glycerin aloe or other ingredient
- the combination of hydrogen peroxide and glycerin has been used as effective local therapy for the treatment of pharyngitis, laryngitis, thrush, gingival infection and necrotizing ulcerative gingivitis.
- the combination being non-toxic, has been found to be effective as a wide spectrum antibacterial and, as described herein, as an antifungal agent.
- the combination When used for treating oral bacterial infections, the combination provides relief from symptoms and serves as an adjunct to systemic therapy. It also relieves pain associated with these conditions, thereby enabling the patient to maintain or resume normal oral intake.
- the combination cleanses the tissue of debris, soothes irritated tissues and aids in restoring good oral hygiene. Patient acceptance has been good. See, for instance, Williams, J.C; Topical Therapy in Infections of the Mouth and Pharynx, Med Times. 91:332-334 (1963).
- Glycerin is quite effective in protecting the skin and buccal membranes of the mouth and oral cavity. FDA monographs, for instance, define glycerin as an "Active Skin Protectant" for use on skin, lips, and the oral cavity.
- hydrogen peroxide for instance at a concentration of between about 1 % and about 3% by weight, based on the weight of the formulation, is useful as a weak antibacterial agent, a wound cleanser (including suppurating ulcers and local infections), and a deodorant.
- hydrogen peroxide is useful for the removal of debris (by virtue of its effervescence) and in the treatment of pharyngitis and Vincent's stomatitis.
- Hydrogen peroxide is also useful as a disinfectant for cuts, burns, and the like, as well as for surfaces such as operating tables and instruments.
- Foams of the present invention provide a convenient, stable form of hydrogen peroxide, capable of providing a time release phenomenon upon breakdown of the foam structure.
- Another preferred chemical agent is natural sea water.
- natural sea water can be stabilized to allow it to be formulated into a product for topical application, e.g. , incorporated as a "chemical agent" in a formulation of the present invention.
- natural sea water can be collected from any suitable source, preferably a well that provides a constant and convenient source.
- the water is then aerated and passed sequentially through a sequential series of pre-filters, e.g., gravel, sand, and finally activated carbon.
- the water is finally passed through a suitable sub-micron (preferably 0.2 micron or less) filter.
- a suitable sub-micron preferably 0.2 micron or less
- one or more preservatives are added to the sub- micron filtered sea water in order to further lengthen its storage stability and preserve its utility.
- suitable preservatives will be well within the skill of those in the cosmetics arts, given the present disclosure.
- Preferred preservatives for sea water include those of the paraben series, and particularly methyl paraben and/or propyl paraben, which can be added to achieve final concentrations in the range of about 0.05% to about 0.5%, and preferably between about 0.1% and about 0.3%.
- Phenonip preservative is described as a mixture of p-hydroxybenzoate esters
- sea water When prepared and used in the manner described herein, sea water provides a number of unexpected and desirable properties.
- a chemical agent in a delivery formulation of the present invention it is preferably used at a final concentration of between about 1 % and about 10% by weight, and preferably between about 3% and about 5% by weight of the concentrate used to prepare the final formulation. It can serve, for instance, as a replacement for added salts in a formulation.
- purified, stable sea water provides a useful thickening effect on foams. Those skilled in the art will appreciate the manner in which this effect can be controlled and used to one's advantage.
- Systems of the present invention can be prepared in any suitable manner, using techniques and equipment within the skill of those in the art. See, e.g., D. Klein, "Toothpastes", Chapter 14, pp. 511-532 in Pharmaceutical Dosage Forms - Disperse Systems. Marcel Dekker, Inc. 1989, the disclosure of which is incorporated herein by reference.
- a preferred system as identified above can be prepared as follows: (1) the desired ingredients are selected, based upon their known properties;
- Formulations can be provided in either of two forms, either as a homogeneous prefabricated formulation that is already contained within an aerosol dispenser, or as a formulation that can optionally be modified (e.g., diluted) for use and added to an aerosol dispenser.
- the final system can be prepared by any suitable means, including by either of two common approaches.
- the formulation generally cooled to below 0 degrees C
- the refrigerated propellant are measured into open containers (usually chilled).
- the valve-actuator assembly is then crimped onto the container to form a pressure-tight seal.
- sufficient volatilization of propellant occurs to displace air from the container.
- the "pressure fill” approach the formulation is placed in the container and either the propellant is forced under pressure through the valve orifice after the valve is sealed, or the propellant is allowed to flow under the valve cap and then the valve assembly is sealed ("under the cap” filling). In both of these "pressure fill” cases, provisions must be made for the evacuation of air by means of vacuum or displacement with a small amount of propellant.
- GRAS general recognized as safe
- the dispenser can be filled and packaged using techniques within the skill of those in the art. For instance, a typical filling ratio is 60% product to 40% compressed air, according to FDA regulations. Special filling heads are used to fill and pressurize the system. Examples of suitable chemical agents (and their intended use) include the following (percentages are provided on a weight basis, based on the weight of the final formulation):
- oils such as perfume oils, particularly in formulations in which the sodium lauryl sulfate serves the additional purpose of holding such oils in solution or stable suspension;
- - aloe vera e.g., between about 0.1 and 10 g/100 ml formulation, and preferably between about 0.3 and 1 g/100 ml
- - sodium chloride e.g., at physiological concentrations, generally about
- Suitable solvents for use in preparing a chemical agent solution of the present invention are those that provide an optimal combination of such properties as: the ability to solubilize the desired chemical agent; compatibility with the system; and suitability for topical use.
- An example of a particularly preferred solvent is purified water.
- other adjuvants such as fluoride, buffering agents, stabilizers and preservatives, foaming agents, antioxidants, flavorings, colors, viscosity modifiers, therapeutic additives, humectants, and binding agents can be used as well.
- the system of the present invention is stable in storage, e.g., it can be stored one or more years without noticeable effect on its desired properties. It is preferably stored in a closed container and at room temperature.
- the system of the present invention provides a unique and desirable combination of such properties as ease of use, aesthetic appearance, formulation stability, uniform distribution of active ingredients, ease of spreading and penetration, and release and availability of medication on contact with dermatomucosal surfaces.
- the system is well-suited for the delivery of formulations that have not previously been delivered in the form of foams, for instance, for the delivery of hydrogen peroxide to the oral cavity.
- foams When used for cleansing minor wounds or irritations of the mouth or gums, a small amount of the foam or spray is dispensed and applied to the affected area. It is allowed to remain in place for about 1 minute, and then expectorated.
- the foam or spray can be used up to 4 times daily (after meals and at bedtime) or as directed by a dentist of physician. Children younger than 12 years of age should be supervised by an adult in the use of the foam, and for children younger than 2 years of age, a dentist or physician should be consulted prior to use.
- the system is particularly well suited for the delivery of formulations that are not generally delivered in the form of foams, including for the delivery of dentifrices, including dental liquids, mouthwashes, oral lavages and gargles that contain hydrogen peroxide.
- formulations that are not generally delivered in the form of foams, including for the delivery of dentifrices, including dental liquids, mouthwashes, oral lavages and gargles that contain hydrogen peroxide.
- the sodium lauryl sulfate was used as a delivery agent and hydrogen peroxide as a cleansing or antiseptic agent.
- the ingredients were mixed in a variety of relative concentrations and a dispenser was filled with the formulation.
- the system was used by actuating the valve in order to generate a foam from the nozzle. At optimal concentrations of ingredients a foam rapidly appeared in direct response to the pressure applied to the valve.
- the foam was a stable one, in that it remains on the skin with little visible shrinkage, yet it easily collapsed when rubbed between the fingers or palms.
- the system is useful for a wide variety of applications, and particularly for applications in which the use of hydrogen peroxide is indicated and where the use of liquid hydrogen peroxide is inconvenient or ineffective.
- the concentrate was prepared having the ingredients provided below:
- sea water was filtered and preserved with (0.2%) methyl paraben in the manner described above, and used with deionized water in the ratio of 1 part sea water to 14 parts deionized water in order to provide an isosmotic formulation.
- sea water and deionized water can be used at any suitable ratio, and preferably between the ratio of about 1 part sea water to 2 parts deionized water, and the ratio of about 1 part sea water to 30 parts deionized water.
- the sodium lauryl sulfate was used as a delivery agent and the natural sea water was used for its purported healing effects.
- the ingredients were mixed in a variety of relative concentrations and dispensers were filled with the formulations using conventional techniques. The system was used by actuating the valve in order to generate a foam from the nozzle. At optimal concentrations of ingredients a foam rapidly appeared in direct response to the pressure applied to the valve. The foam was a stable one in that it with little visible shrinkage, yet it when rubbed between the fingers or palms.
- the system is useful for a wide variety of applications, and particularly for applications in which the use of sea water is indicated and where the use of fresh sea water is inconvenient or ineffective.
- Propellant A-46 25 g The concentrate was prepared in the order, and having the ingredients, provided below:
- Glycerin skin conditioning agent, humectant
- TEA lauryl sulfate (40.0%) (surfactant, emulsifying 1.8 agent) 3.
- Mineral oil (skin conditioning agent, emollient) 0.9
- Shea butter biological additive, skin conditioning 0.9 agent
- Polysorbate-60 polyoxyethylene sorbitan 0.3 monostearate (Tween 60) - surfactant, emulsifying agent
- the ingredients were mixed in a variety of relative concentrations and a 2.5 ounce can dispenser was filled with the formulations.
- the system was used by actuating the valve in order to generate a foam from the nozzle. At optimal concentrations of ingredients a foam rapidly appeared in direct response to the pressure applied to the container.
- the foam is formulated to be useful as a skin covering, to be rubbed over the entire hands to form a protective film - not unlike the protection afforded by a glove.
- Concentrate IV was prepared having the same ingredients and concentrations as set forth above with respect to Concentrate HI, although omitting the sunprotecting agents and using instead a total volume of 70% (rather than 62%) deionized water. Concentrate IV was used to fill 4.5 ounce can dispensers.
- the foamed formulation could be used by spreading it over the hands to provide a protective "glove-like" covering.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
A system for delivering a chemical agent in the form of a foam, which in its preferred embodiment involves the use of an aerosol dispenser to deliver a formulation containing both an anionic surface active agent such as sodium lauryl sulfate as a delivery agent and a chemical agent such as either hydrogen peroxide as a disinfecting chemical agent or natural sea water.
Description
TOPICAL FORMULATIONS AND DELIVERY SYSTEMS
TECHNICAL FIELD
The present invention relates to topical and other hygiene formulations, and to aerosol devices useful for the delivery of such formulations in the form of lathers and foams. In another aspect, the invention relates to formulations useful in the oral cavity, such as dentifrices containing hydrogen peroxide. In yet another aspect, the invention relates to the pharmacological use of surfactants such as anionic surfactants, and in particular sodium lauryl sulfate. In a further aspect the invention relates to topical and other hygiene formulations containing natural sea water.
BACKGROUND ART Delivery Devices.
Formulations such as cosmetics and pharmaceuticals can be dispensed in a wide variety of vehicles and forms, including powders, capsules, liquids, aerosols, and the like. In particular, the delivery of formulations by the aerosol route is generally considered to take one of three forms: (1) the use of "space sprays", such as spray insecticides and air fresheners, which produce very fine sprays capable of evaporating rapidly or floating in the air; (2) the use of sprays such as hair sprays and deodorants, that are intended for continuous film formation; and (3) the use of aerated foams, such as shaving creams, which are produced by the rapid expansion of a propellant through an emulsion.
A variety of dispensers have been described for the purpose of delivering formulations of these various types. See, e.g., H. Mintzer, "Aerosols", Chapter 10 in Pharmaceutical Dosage Forms - Disperse Systems. Marcel Dekker, Inc. pp. 204-220 (1989). Aerosols for oral and nasal therapy are generally said to incorporate medicaments as solids suspended in a propellant. More recent advances in valve and propellant technology are said to provide improved delivery to the throat and nasal areas. Formulations delivered in aerosol form by the use of
such devices can often include the use of surfactants. For instance, surfactants are commonly used in nebulizer vehicles to decrease surface tension and thus affect particle size (Mintzer, above, p. 206).
Yet other types of aerosol containers, pressurized with nitrogen, have been used to dispense toothpaste through a dip tube and foam-style valve. For a variety of reasons, however, such containers have not been commercially successful. See, e.g., D. Garten, "Toothpastes", Chapter 14, pp. 511-532 in Pharmaceutical Dosage Forms - Disperse Systems. Marcel Dekker, Inc. 1989. As a result, various forms of "pump" dispensers have been developed for delivering toothpaste, the pumps relying on the use of a spring device to force the toothpaste out of a spout.
Surfactants.
On a separate subject, a large number of surfactants, including sodium lauryl sulfate ("SLS"), have been widely used and found safe in a variety of cosmetic products, including dentrifices. See, e.g., "Surfactants in Oral Hygiene
Products", pp. 299-347 in Surfactants in Cosmetics. M. Reiger ed., Marcel Dekker, Inc. 1985.
As of 1992, SLS itself was present in over 500 oral solid dosage forms approved by the FDA, as well as in 11 oral liquid dosage forms, 38 topical creams, lotions, ointments, medicates sponges or shampoos, and 28 dentrifices.
CRC Handbook of Food. Drug and Cosmetic Excipients. S. Smolinske, pp. 359- 362 (1992). The usefulness of sodium lauryl sulfate as a synthetic detergent in toothpaste has been studied in a recent article by P. Barkvoll. ("Should toothpastes foam? Sodium lauryl sulfate - a toothpaste detergent in focus", Norske Tannlaegeforenings Tidende 99(3)82-4 (1989)).
U.S. Patent Nos. 4,657,758 and 4,666,708, for instance, describe dental rinses for loosening plaque and preventing plaque build-up. The rinses described in both patents rely on the detersive effect of oral surfactants. The '708 patent describes the use of SLS as one such oral surfactant, and further describes its function as a "potentiator" for other ingredients. In the Examples, patients were instructed to use one tablespoon of various rinses. Such rinse products, which are
commercially available under the brand name "Plax", are typically swirled in the mouth in order to produce a weak foaming action.
Chemical Agents.
On yet another subject, there exist a number of useful chemical agents that, for one reason or another, have not previously been prepared in the form of a foamable composition, or delivered in the form of a foam or aerosol spray.
Natural sea water, for instance, has long been thought to provide certain desirable, including healing, qualities. See, for instance, Richard Russel, A Dissertation on the use of Sea Water in the Diseases of the Glands: Particularly the Scurvy. Jaundice. King's Evil. Leprosy and the Glandular Consumption.
Preface (pages i - xii), (1769). Rarely, however, is sea water packaged and used for such purposes. This may be due to the present inability of the art to reproducibly prepare and package sea water in a stable form suitable for such use. Hydrogen peroxide, for instance, is a common ingredient in mouthwashes and gargles. (See, e.g., "Mouthwashes and Gargles", p. 1680, in American
Hospital Formulary Services - Drug Information 1992, G. McEvoy et al. eds., American Society of Hospital Pharmacists). Hydrogen peroxide functions as a weak antibacterial agent, a wound cleanser and a deodorant. It also serves a mechanical effect of effervescence and resultant removal of tissue and other debris.
When used as an oral topical, however, hydrogen peroxide is typically administered in the form of a concentrate, solution, or gel. The product is used for cleansing minor wounds, or minor gum inflammation resulting from dental procedures, orthodontic applications, denture irritations, accidental injury and other mouth and gum irritations (e.g., canker sores).
Such beneficial uses of hydrogen peroxide include its use as an oral germicide, cleansing agent and hemostat. It is considered a useful disinfectant for mucous membranes because of its low toxicity. See, e.g., Zinner. D.D., et. al.; Controlled Study of the Clinical Effectiveness of A New Oxygen Gel on Plaque. Oral Debris and Gingival inflammation, Pharmacol. Ther. Dent.. October 1970,
1:7-15.
Dental products such as "MentaDent", which was recently introduced by Chesebrough-Ponds, relies on the use of hydrogen peroxide. The commercial product identifies related U.S. Patent Nos. 4,687,663, 4,964,539, 5,020,694, 5,038,963, 5,059,417, and Design patent No. D 315,496. Such patents relate variously to the use of a hydrogen peroxide component with a second component containing sodium bicarbonate; to a dentifrice composition containing, inter alia, hydrogen peroxide and a polyoxyethylene-polyoxypropylene copolymer; to multi- cavity or multi-chamber dispensing containers; and to a design for a dispensing container. SLS and hydrogen peroxide have, on occasion, been used together in formulations for the oral cavity. See, for instance, U.S. Patent No. 5,104,644 and 5,174,990 (mouthrinse), 5,084,268 and 5,208,010 (tooth whitening dentifrice).
An application previously filed naming the present inventor, and having US Serial No. 08/218,796, filed March 28, 1994, discloses a system for delivering a chemical agent-containing formulation in the form of a foam, the system comprising a propellantless dispenser containing a foamable formulation comprising the chemical agent in the form of a solution or stable suspension and an aqueous solution of an anionic surface active agent as a foaming agent. Applicant has since found that such dispensers are less preferred, and in many cases unsuitable for such purposes, for a variety of reasons. These reasons include the fact that such dispensers are often subject to mechanical failure, particularly when subjected to agitation or external pressure changes, resulting in the production of inadequate foams.
As a result there continue to be few, if any, instances of the use of devices for the aerosol delivery of formulations to the oral cavity in the form of foams, particularly for formulations that incorporate hydrogen peroxide or sea water, or formulations for use in the oral cavity.
SUMMARY OF THE INVENTION In one aspect, the present invention provides a system useful for delivering chemical agent-containing formulations in the form of foams or sprays. In particular, the invention provides a system for delivering a chemical agent-
containing formulation in the form of a foam or spray, the system comprising an aerosol dispenser containing a formulation comprising the chemical agent in the form of a solution or stable suspension and an aqueous solution of an anionic surface active agent as a delivery agent. In one preferred embodiment, the invention provides a system for delivering a foam or spray such as a disinfecting foam or spray, the system comprising an aerosol dispenser containing a deliverable (e.g., foamable or sprayable) formulation comprising lauryl sulfate, and preferably sodium lauryl sulfate, as a delivery agent. In a preferred embodiment, the system is used to deliver a cleansing, antiseptic, or disinfecting foam comprising hydrogen peroxide as the active agent. Such a system is particularly well suited for the delivery of hydrogen peroxide to the oral cavity, i.e., as a dental or oral formulation.
Applicant has found that the delivery of hydrogen peroxide to the oral cavity in the form of a foam or spray improves the effervescence of the formulation and, in turn, improves the removal of tissue and other debris. The formulation is particularly well suited to suspend and remove food particles and other debris, and then itself be rinsed away quickly. It does not appear that hydrogen peroxide has previously been effectively used for such purposes in the form of a foam or spray in the manner described herein, particularly in a manner suitable for commercial application.
The system of the present invention is capable of producing rapid detergent action in order to instantly provide voluminous quantities of microbubbles from relatively small initial volumes of formulation. This detergent action, in turn, greatly facilitates the effectiveness of the formulation as an oral rinse. The system of the present invention, for instance, can rapidly provide a volume of bubbles from about 2 grams of formulation that is as great or greater than the volume obtained by swirling up to an ounce (e.g., about 25-30 grams) of a product like Plax in the mouth for 30 seconds, as recommended by the manufacturer.
Formulations of the present invention having hydrogen peroxide have also been found to be particularly effective antifungal agents. To the best of
Applicants' knowledge, hydrogen peroxide has not heretofore been approved or
applied as an antifungal agent, and particularly not in the form of a foam or spray, or a composition delivered by an aerosol dispenser.
In another aspect, the present invention provides a method of delivering a formulation in the form of a organoleptically acceptable foam or spray, the preferred method comprising the steps of: (1) providing a formulation comprising a chemical agent to be delivered and sodium lauryl sulfate as a delivery agent, within an aerosol dispenser, and (2) delivering the formulation in the form of a foam or spray by activation of the dispenser.
In yet another aspect, the invention provides purified sea water compositions suitable for use in preparing formulations described herein. It appears that sea water has not heretofore been prepared in a form suitable for use in commercial cosmetic formulations.
DETAILED DESCRIPTION The present invention provides a system for delivering a wide variety of chemical agents in the form of an efficacious foam. As used herein, the following words and terms shall have the meanings ascribed to them:
"system" will refer to an aerosol dispenser containing a formulation; "formulation" will refer to a solution, e.g., as a single phase liquid or stable dispersion, which is capable of being delivered from an aerosol dispenser in the form of a foam or spray;
"chemical agent", in turn, will refer to the active agent or other agent to be delivered in the form of a foam;
"foam", and inflections thereof, when used as a verb shall refer to the ability of a formulation to form a foam when dispensed from an aerosol dispenser, and when used as a noun shall mean a liquid-film matrix with a mass of gas bubbles in it;
"spray", and inflections thereof, when used as a verb shall refer to the ability of a formulation to form a spray when dispensed from an aerosol dispenser, and when used as a noun shall mean a liquid moving in a mass of dispersed droplets, e.g., a fine jet of liquid discharged from a pressurized container,
"delivery agent" shall refer to one or more ingredients in a formulation that functions to cause or facilitate either the foaming or spraying of the formulation when dispensed from an aerosol dispenser; and
"dental formulation" shall refer to any formulation useful in or on the mouth or gums (such as dentifrice, mouthwash, gargle, dental liquid), or other nasopharyngeal application.
Preferred foams of the present invention are substantially stable, yet can be readily broken upon agitation. In other words, the foam is substantially stable after it is formed, so long as it is not agitated. An example of such a foam is one that can be dispensed into the palm of the hand and there remain for at least 30 seconds, and preferably for on the order of minutes, without collapsing. Once agitated however, for instance by rubbing the palms together, the foam is readily broken and in fact essentially disappears within a second or two. Preferred foams are similar in appearance and consistency to the suds obtained by the agitation of dishwashing liquids, that is, they are comprised of small bubbles.
While not intending to be bound by theory, it is believed that the unique combination of SLS as a delivery agent within an aerosol dispenser of the type described herein, together with chemical agents such as hydrogen peroxide, provide an optimal combination of such unexpected qualities as deliverability, foaming, effervescence, and cleaning ability.
Dispensers suitable for use in the system of the present invention are typically those that are capable of creating and dispensing a formulation in the form of a foam or spray in an aerosol manner through the use of a relatively low boiling liquid propellant such as butane and propane. The word "aerosol" will refer herein to the delivery of a foam or spray in a manner that employs a hydrocarbon or other suitable propellant, as further explained herein.
Aerosol dispensers are distinct from "propellantless" dispensers, the latter type being narrowly defined as those that avoid the use of a pressurized gas to achieve rapid expansion of a propellant through an emulsion. Propellantless dispensers are those that rely on the use of compressed air, for instance obtained by squeezing a bottle, as opposed to piston-type or spring-loaded dispensers.
In addition to a composition, a system of the present invention further comprises a dispenser, i.e., a container useful for holding one or more propellants, a valve, and an actuator. Those skilled in the are will be able to determine the manner in which the nature of these components can be selected and altered to determine such characteristics as delivery rate and uniformity, wetness and temperature of the foam or spray, foam or spray density, and the like.
Suitable aerosol dispensers provide an optimal combination of such properties as ease of use, capacity, inertness, safety and cost. Examples of suitable dispensers include those prepared of glass, plastic, metal or a combination of such materials. Glass containers must be carefully selected to provide an optimal level of pressure safety and impact resistance. Plastics may be employed to coat glass containers for improved safety, or to coat metal containers to improve corrosion resistance and enhance formulation stability.
The propellant supplies the necessary pressure within an aerosol system to expel the formulation from the container and, in combination with other components, to convert the formulation into the desired foam. Propellants may be broadly classified as liquified or compressed gases having vapor pressures generally exceeding atmospheric. Propellants within this definition include various hydrocarbons, especially fluoro-chloro- derivatives of methane and ethane, low molecular weight hydrocarbons such as the propanes, butanes and pentanes, and compressed gases such as carbon dioxide, nitrogen and nitrous oxide.
Preferred propellants suitable for use in the system of the present invention provide an optimal combination of such properties as compatibility and cost. Examples of preferred propellants include, but are not limited to, butane, dichlorodifluoromethane, dichlorotetrafluoroethane, isobutane, propane, trichloromonofluoromethane, and mixtures thereof.
Suitable propellants are commercially available from a number of sources, for instance, those identified as "Aeropres 46 (A-46)", a mixture of propane and isobutane available from Aeropres Corporation, Shreveport LA. Those skilled in the art, given the instant specification, will be able to identify and incorporate suitable valves and actuators for use in a system of the invention. The primary function of the valve is to regulate the flow of the
formulation and propellant from the container. The characteristics of the delivered foam, including the accuracy and reproducibility of the delivery, should be optimized. Plastic, rubber, aluminum and stainless steel valves are particularly preferred. An actuator is a fitting attached to an aerosol valve stem which, when depressed or moved, opens the valve to permit a foam or spray to issue from the container, and directs the foam or spray containing the formulation to the desired area. The actuator usually indicates the direction in which the formulation is dispensed and protects the hands or fingers from the refrigerant effects of the propellant. Actuators can incorporate an orifice of any suitable size and shape.
Those skilled will appreciate the manner in which the orifice, the expansion chamber design, and the nature of the propellant and formulation can be adapted to modify the physical characteristics of the dispersed foam or spray.
A system of the present invention comprises a delivery agent, preferably selected from the class of surface active agents known as anionic detergents.
Examples of suitable anionic delivery agents include sodium cocomonoglyceride sulfonate, sodium lauryl sarcosinate, sodium dodecyl benzenesulfonate, and miscellaneous other surfactants such as dioctyl sodium sulfosuccinate, sodium lauryl sulfoacetate, sulfolaurate, and the 2-hydroxyalkyl sulfates. See, e.g., "Surfactants in Oral Hygiene Products", pp. 299-347 in Surfactants in Cosmetics.
M. Reiger ed., Marcel Dekker, Inc. 1985, the disclosure of which is incorporated herein by reference.
A particularly preferred delivery agent is SLS. SLS is itself classified as an emulsifying, wetting, and/or solubilizing agent. SLS is actually a mixture of sodium alkyl sulfates, primarily sodium lauryl sulfate containing not more than a total of 8% of sodium sulfate and sodium chloride. SLS is a long-chain fatty alcohol sulfate, and commercially available forms of SLS involve a mixture of long-chain saturated alkyl alcohols. Oral grades of SLS are generally made from naturally occurring fats and oils, mostly from coconut fatty acids, or the like. Some products are virtually all dodecyl derivative, while others contain mixtures of dodecyl, tetradecyl, and higher derivatives, depending on the degree of fractionation of the original fatty acids.
Such surface active agents, including SLS, are preferably present in the formulation at a final concentration of between about 0.05% and about 5% , and more preferably between about 0.1 % and about 1 % , by weight, based on the weight of the chemical agent formulation. Formulations containing less than about 0.5% SLS tend to have poor foaming characteristics, while those containing greater than about 5% SLS tend to impart unpleasant taste or other undesirable characteristics to the formulation.
The formulation delivered using a system of the present invention preferably comprises a chemical agent. Suitable chemical agents include any compound, solution or molecule that is desired to be delivered as a foam or spray to the body, including any cavity of the body. Examples of chemical agents that can be delivered to the body in the form of a foam or spray include topical analgesics, anesthetics, antibacterials, antibiotics, antifungal agents, anti- inflammatory agents (such as salicylates and steroids), antineoplastics, antiparasitics, antipruritics, antiviral agents, biologicals, contraceptives, dental preparations, deodorants, enzymes and digestants, germicides, hemorrhoidal preparations, hormones, minerals, vaginal preparations, and the like. Specific examples of preferred chemical agents include povidone iodine and hexachlorophene. In a preferred embodiment, the system of the present invention is used for the preparation of foams for the application of abradants, antiacne preparations, antibacterials and/or antifungals, antidermatitis preparations, as well as antiherpes, anti-inflammatory, antiperspiration, antipuritics, antipsoriasis, antiseborrhea, or astringent agents, coal tar, depigmenting agents, detergents, emollients, fungicides, keratolytics, moisturizers, pediculicides, photosensitizers, scabicides, skin bleaches, skin protectants, cleansers, steroids, sulfur and salicylic acid, sun screens, vesicants, wart therapeutic agents, wound dressings, and the like.
Particularly preferred is a formulation that contains both hydrogen peroxide (as an anti-infective agent) and glycerin, aloe or other ingredient (as a skin or tissue protectant). The combination of hydrogen peroxide and glycerin has been used as effective local therapy for the treatment of pharyngitis, laryngitis, thrush, gingival infection and necrotizing ulcerative gingivitis. The combination, being
non-toxic, has been found to be effective as a wide spectrum antibacterial and, as described herein, as an antifungal agent.
When used for treating oral bacterial infections, the combination provides relief from symptoms and serves as an adjunct to systemic therapy. It also relieves pain associated with these conditions, thereby enabling the patient to maintain or resume normal oral intake. The combination cleanses the tissue of debris, soothes irritated tissues and aids in restoring good oral hygiene. Patient acceptance has been good. See, for instance, Williams, J.C; Topical Therapy in Infections of the Mouth and Pharynx, Med Times. 91:332-334 (1963). Glycerin is quite effective in protecting the skin and buccal membranes of the mouth and oral cavity. FDA monographs, for instance, define glycerin as an "Active Skin Protectant" for use on skin, lips, and the oral cavity.
Similarly, hydrogen peroxide, for instance at a concentration of between about 1 % and about 3% by weight, based on the weight of the formulation, is useful as a weak antibacterial agent, a wound cleanser (including suppurating ulcers and local infections), and a deodorant. When used in a dentifrice, hydrogen peroxide is useful for the removal of debris (by virtue of its effervescence) and in the treatment of pharyngitis and Vincent's stomatitis. Hydrogen peroxide is also useful as a disinfectant for cuts, burns, and the like, as well as for surfaces such as operating tables and instruments. Foams of the present invention provide a convenient, stable form of hydrogen peroxide, capable of providing a time release phenomenon upon breakdown of the foam structure.
Another preferred chemical agent is natural sea water. In stark contrast to the teachings of science and legend, Applicant has discovered a method in which natural sea water can be stabilized to allow it to be formulated into a product for topical application, e.g. , incorporated as a "chemical agent" in a formulation of the present invention.
In a preferred embodiment natural sea water can be collected from any suitable source, preferably a well that provides a constant and convenient source. The water is then aerated and passed sequentially through a sequential series of pre-filters, e.g., gravel, sand, and finally activated carbon. After the optional pre- filter step(s) the water is finally passed through a suitable sub-micron (preferably
0.2 micron or less) filter. The resulting water surprisingly retains most, if not all, of the qualities desirable for cosmetic use, is stable upon prolonged storage, and can be used to provide stable effective formulations of the present invention.
Optionally, and preferably, one or more preservatives are added to the sub- micron filtered sea water in order to further lengthen its storage stability and preserve its utility. The identification of suitable preservatives will be well within the skill of those in the cosmetics arts, given the present disclosure. Preferred preservatives for sea water include those of the paraben series, and particularly methyl paraben and/or propyl paraben, which can be added to achieve final concentrations in the range of about 0.05% to about 0.5%, and preferably between about 0.1% and about 0.3%.
Commercial grade cosmetic and pharmaceutical preservative compositions are available, such as the liquid preservatives provided under the tradename "Phenonip" available from NIPA LABORATORIES, INC., Wilmington, DE. Phenonip preservative is described as a mixture of p-hydroxybenzoate esters
(approximately 35 % in combined weight) in 2-phenoxyethanol.
When prepared and used in the manner described herein, sea water provides a number of unexpected and desirable properties. When used as a chemical agent in a delivery formulation of the present invention, it is preferably used at a final concentration of between about 1 % and about 10% by weight, and preferably between about 3% and about 5% by weight of the concentrate used to prepare the final formulation. It can serve, for instance, as a replacement for added salts in a formulation. In particular, it has been found that purified, stable sea water provides a useful thickening effect on foams. Those skilled in the art will appreciate the manner in which this effect can be controlled and used to one's advantage.
Systems of the present invention can be prepared in any suitable manner, using techniques and equipment within the skill of those in the art. See, e.g., D. Garten, "Toothpastes", Chapter 14, pp. 511-532 in Pharmaceutical Dosage Forms - Disperse Systems. Marcel Dekker, Inc. 1989, the disclosure of which is incorporated herein by reference.
A preferred system as identified above can be prepared as follows:
(1) the desired ingredients are selected, based upon their known properties;
(2) the ingredients are mixed, together with adjuvants, according to methods within the skill of those in the art;
(3) the compatibilities of ingredients are evaluated for use in preparation and storage;
(4) the stability and potency of ingredients is assured; and
(5) the resultant system is properly packaged and labeled for storage, transport, and use.
Formulations can be provided in either of two forms, either as a homogeneous prefabricated formulation that is already contained within an aerosol dispenser, or as a formulation that can optionally be modified (e.g., diluted) for use and added to an aerosol dispenser.
The final system can be prepared by any suitable means, including by either of two common approaches. In an approach known as the "cold fill" approach, the formulation (generally cooled to below 0 degrees C) and the refrigerated propellant are measured into open containers (usually chilled). The valve-actuator assembly is then crimped onto the container to form a pressure-tight seal. During the period between propellant addition and crimping, sufficient volatilization of propellant occurs to displace air from the container. In another approach, the "pressure fill" approach, the formulation is placed in the container and either the propellant is forced under pressure through the valve orifice after the valve is sealed, or the propellant is allowed to flow under the valve cap and then the valve assembly is sealed ("under the cap" filling). In both of these "pressure fill" cases, provisions must be made for the evacuation of air by means of vacuum or displacement with a small amount of propellant.
Other chemical agents and formulations useful with the system of the present invention can be prepared using a combination of commonly available ingredients identified as "generally recognized as safe" ("GRAS"). The dispenser can be filled and packaged using techniques within the skill of those in the art. For instance, a typical filling ratio is 60% product to 40% compressed air, according to FDA regulations. Special filling heads are used to fill and pressurize the system.
Examples of suitable chemical agents (and their intended use) include the following (percentages are provided on a weight basis, based on the weight of the final formulation):
- essential oils, such as perfume oils, particularly in formulations in which the sodium lauryl sulfate serves the additional purpose of holding such oils in solution or stable suspension;
- aloe vera (e.g., between about 0.1 and 10 g/100 ml formulation, and preferably between about 0.3 and 1 g/100 ml), used either with or without hydrogen peroxide; - sodium chloride (e.g., at physiological concentrations, generally about
0.9%), for use in treating cold sores and fever blisters and lesions associated with Herpes virus;
- hydrogen peroxide (e.g., about 1 % to about 15% , preferably about 8% to about 12%). Suitable solvents for use in preparing a chemical agent solution of the present invention are those that provide an optimal combination of such properties as: the ability to solubilize the desired chemical agent; compatibility with the system; and suitability for topical use. An example of a particularly preferred solvent is purified water. In a particularly preferred embodiment, other adjuvants such as fluoride, buffering agents, stabilizers and preservatives, foaming agents, antioxidants, flavorings, colors, viscosity modifiers, therapeutic additives, humectants, and binding agents can be used as well.
The system of the present invention is stable in storage, e.g., it can be stored one or more years without noticeable effect on its desired properties. It is preferably stored in a closed container and at room temperature.
In use, the system of the present invention provides a unique and desirable combination of such properties as ease of use, aesthetic appearance, formulation stability, uniform distribution of active ingredients, ease of spreading and penetration, and release and availability of medication on contact with dermatomucosal surfaces.
The system is well-suited for the delivery of formulations that have not previously been delivered in the form of foams, for instance, for the delivery of hydrogen peroxide to the oral cavity. When used for cleansing minor wounds or irritations of the mouth or gums, a small amount of the foam or spray is dispensed and applied to the affected area. It is allowed to remain in place for about 1 minute, and then expectorated. The foam or spray can be used up to 4 times daily (after meals and at bedtime) or as directed by a dentist of physician. Children younger than 12 years of age should be supervised by an adult in the use of the foam, and for children younger than 2 years of age, a dentist or physician should be consulted prior to use.
The system is particularly well suited for the delivery of formulations that are not generally delivered in the form of foams, including for the delivery of dentifrices, including dental liquids, mouthwashes, oral lavages and gargles that contain hydrogen peroxide. The following Examples are given to illustrate, but not limit, the scope of this invention. Unless otherwise indicated, all percentages are by weight.
EXAMPLES EXAMPLE 1 3% Hydrogen Peroxide A number of systems according to the present invention were prepared having the following ingredients:
Concentrate I 145 g
Propellant "A-46" 25 g
Concentrate I was prepared having the ingredients provided below:
Suitable range (%) Concentrate I ( %)
Deionized water to 100 to 100
Hydrogen Peroxide 3 3
Aloe vera gel 0 - 3 1
Methyl paraben 0.05 - 0.5 0.2
Sodium lauryl sulfate 0.2 - 3 1
Fragrance 0 - 1 -
The sodium lauryl sulfate was used as a delivery agent and hydrogen peroxide as a cleansing or antiseptic agent. The ingredients were mixed in a variety of relative concentrations and a dispenser was filled with the formulation. The system was used by actuating the valve in order to generate a foam from the nozzle. At optimal concentrations of ingredients a foam rapidly appeared in direct response to the pressure applied to the valve. The foam was a stable one, in that it remains on the skin with little visible shrinkage, yet it easily collapsed when rubbed between the fingers or palms.
The system is useful for a wide variety of applications, and particularly for applications in which the use of hydrogen peroxide is indicated and where the use of liquid hydrogen peroxide is inconvenient or ineffective.
EXAMPLE 2 Body Foam with Sea Water A number of systems according to the present invention were prepared having the following ingredients:
Concentrate II 145 g
Propellant A-46 25 g
The concentrate was prepared having the ingredients provided below:
Suitable ranpe (%) Concentrate II (%)
Sea water/Deionized water to 100 to 100
Aloe vera gel 0 - 3 1
Methyl paraben 0.05 - 0.5 1
Sodium lauryl sulfate 0.2 - 3 1
Fragrance 0 - 1 -
The sea water was filtered and preserved with (0.2%) methyl paraben in the manner described above, and used with deionized water in the ratio of 1 part sea water to 14 parts deionized water in order to provide an isosmotic formulation. In alternative embodiments, sea water and deionized water can be used at any suitable ratio, and preferably between the ratio of about 1 part sea water to 2 parts
deionized water, and the ratio of about 1 part sea water to 30 parts deionized water.
The sodium lauryl sulfate was used as a delivery agent and the natural sea water was used for its purported healing effects. The ingredients were mixed in a variety of relative concentrations and dispensers were filled with the formulations using conventional techniques. The system was used by actuating the valve in order to generate a foam from the nozzle. At optimal concentrations of ingredients a foam rapidly appeared in direct response to the pressure applied to the valve. The foam was a stable one in that it with little visible shrinkage, yet it when rubbed between the fingers or palms.
The system is useful for a wide variety of applications, and particularly for applications in which the use of sea water is indicated and where the use of fresh sea water is inconvenient or ineffective.
EXAMPLE 3 Foaming Skin Protectant/Tanning Accelerator with Sea Water
A number of systems according to the present invention were prepared having the following ingredients:
Concentrate III 70 g
Propellant A-46 25 g The concentrate was prepared in the order, and having the ingredients, provided below:
Step Ingredient (functionCs)') Concentrate III
(approx. %)
1. Deionized water (solvent) 62
Sea water (solvent, chemical agent) 4
Aloe vera powder (skin conditioner) 0.1
Triethanolamine (pH adjuster) 0.75
Propylene glycol (solvent, humectant) 3.7
Glycerin (skin conditioning agent, humectant) 3.2
TEA lauryl sulfate (40.0%) (surfactant, emulsifying 1.8 agent)
3. Mineral oil (skin conditioning agent, emollient) 0.9
Sorbitol (70.0%) (skin conditioning agent, humectant) 1.7
Shea butter (biological additive, skin conditioning 0.9 agent)
Dimethicone (350) (skin conditioning agent) 0.1
Lauramide DEA (surfactant) 0.9
Stearic acid (surfactant, skin conditioning agent) 8.7
Polysorbate-60 (polyoxyethylene sorbitan 0.3 monostearate (Tween 60) - surfactant, emulsifying agent)
Sorbitan stearate (surfactant, emulsifying agent) 0.58
Octyl methoxycinnamate (sunscreen) 4
Benzophenone-3 (sunscreen) 2
Octyl salicylate (sunscreen) 3
4. Germaben II-E (preservative) 0.7
5. Sodium silicate (buffering agent, corrosion inhibitor, 0.46 pH adjuster)
The ingredients were mixed in a variety of relative concentrations and a 2.5 ounce can dispenser was filled with the formulations. The system was used by actuating the valve in order to generate a foam from the nozzle. At optimal concentrations of ingredients a foam rapidly appeared in direct response to the pressure applied to the container.
The foam is formulated to be useful as a skin covering, to be rubbed over the entire hands to form a protective film - not unlike the protection afforded by a glove.
The system is useful for a wide variety of applications, and particularly for applications in which the use of sea water is indicated and where the use of fresh sea water is inconvenient or ineffective.
EXAMPLE 4 Foaming Skin Protectant with Sea Water A number of systems according to the present invention were prepared having the following ingredients: Concentrate IV 145 g
Propellant A-46 25 g
Concentrate IV was prepared having the same ingredients and concentrations as set forth above with respect to Concentrate HI, although omitting the sunprotecting agents and using instead a total volume of 70% (rather than 62%) deionized water. Concentrate IV was used to fill 4.5 ounce can dispensers.
Again, at optimal concentrations within the ranges set forth, the foamed formulation could be used by spreading it over the hands to provide a protective "glove-like" covering.
The present invention has been described with reference to various embodiments thereof. It will be apparent to those skilled in the art that many changes can be made in the embodiments described without departing from the scope of the present invention. Thus the scope of the present invention should not be limited to the formulations described in this application, but only by formulations described by the language of the claims and the equivalents of those formulations.
Claims
1. A system for delivering a chemical agent-containing formulation in the form of a spray or stable foam, the system comprising an aerosol dispenser containing a formulation comprising the chemical agent in the form of a solution or stable suspension and an aqueous solution of an anionic surface active agent as a delivery agent.
2. A system according to claim 1 wherein the surface active agent is selected from the group consisting of sodium lauryl sulfate, sodium cocomonoglyceride sulfonate, sodium lauryl sarcosinate, sodium dodecyl benzenesulfonate, dioctyl sodium sulfosuccinate, sodium lauryl sulfoacetate, sulfolaurate, and the 2-hydroxyalkyl sulfates.
3. A system according to claim 2 wherein the surface active agent comprises sodium lauryl sulfate.
4. A system according to claim 3 wherein sodium lauryl sulfate is present at a concentration of between about 0.1 % and about 1 %, by weight, based on the weight of the formulation.
5. A system according to claim 3 wherein the formulation comprises hydrogen peroxide as the chemical agent.
6. A system according to claim 5 wherein the formulation is an oral formulation.
7. A system according to claim 5 wherein the formulation further comprises glycerin.
8. A system according to claim 5 wherein the hydrogen peroxide is present at a concentration of between about 1 % and about 3%, by weight, based on the weight of the formulation.
9. A system according to claim 3 wherein the chemical agent comprises purified sea water.
10. A system according to claim 9 wherein the sea water is used in an amount sufficient to provide an isoosmotic formulation.
11. A method of delivering a chemical agent-containing formulation in the form of a spray or stable foam, the method comprising the steps of: (1) providing an aerosol dispenser containing a formulation comprising the chemical agent and an anionic surface active agent as a delivery agent, and (2) delivering the formulation in the form of a spray or stable foam by activation of the dispenser.
12. A method according to claim 11 wherein the surface active agent is selected from the group consisting of sodium lauryl sulfate, sodium cocomonoglyceride sulfonate, sodium lauryl sarcosinate, sodium dodecyl benzenesulfonate, dioctyl sodium sulfosuccinate, sodium lauryl sulfoacetate, sulfolaurate, and the 2-hydroxyalkyl sulfates.
13. A method according to claim 12 wherein the surface active agent comprises sodium lauryl sulfate.
14. A method according to claim 13 wherein sodium lauryl sulfate is present at a concentration of between about 0.1 % and about 1%, by weight, based on the weight of the formulation.
15. A method according to claim 13 wherein the formulation comprises hydrogen peroxide as the chemical agent.
16. A method according to claim 15 wherein the formulation is an oral formulation.
17. A method according to claim 15 wherein the formulation further comprises glycerin.
18. A method according to claim 15 wherein the hydrogen peroxide is present at a concentration of between about 1 % and about 3%, by weight, based on the weight of the formulation.
19. A method according to claim 13 wherein the chemical agent comprises purified sea water.
20. A method according to claim 19 wherein the sea water is used in an amount sufficient to provide an isoosmotic formulation.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US416795P | 1995-09-22 | 1995-09-22 | |
| US60416 | 1995-09-22 | ||
| PCT/US1996/015596 WO1997010802A1 (en) | 1995-09-22 | 1996-09-20 | Topical formulations and delivery systems |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0862407A1 true EP0862407A1 (en) | 1998-09-09 |
| EP0862407A4 EP0862407A4 (en) | 1999-03-03 |
Family
ID=21709507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP96936055A Withdrawn EP0862407A4 (en) | 1995-09-22 | 1996-09-20 | Topical formulations and delivery systems |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP0862407A4 (en) |
| CA (1) | CA2232677A1 (en) |
| WO (1) | WO1997010802A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69821010T2 (en) * | 1997-10-02 | 2004-10-28 | Oms Holdings, Llc | AEROSOL SALBEN-PREPARATIONS |
| EP1074245A3 (en) * | 1999-08-06 | 2001-05-30 | Sam Schwartz | Composition using mineral salts for therapeutic treatment |
| GB2380231A (en) * | 2001-09-26 | 2003-04-02 | Reckitt Benckiser Nv | Corrosion inhibitors for tin plated aerosol canisters |
| ITMI20020884A1 (en) * | 2002-04-23 | 2003-10-23 | Farmaceutici S R L | NON-ABRASIVE WHITENING TOOTHPASTE COMPOSITION |
| ITMI20022781A1 (en) * | 2002-12-30 | 2004-06-30 | Farmaceutici S R L | COMPOSITION FOR TOPICAL ACTION DERMATOLOGICAL PRODUCTS AND DERMATOLOGICAL PRODUCTS MADE WITH THIS COMPOSITION. |
| US20070148101A1 (en) * | 2005-12-28 | 2007-06-28 | Marcia Snyder | Foamable alcoholic composition |
| US9561161B2 (en) | 2013-05-07 | 2017-02-07 | Michael Florman | Method of cleaning an oral appliance |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1520945A (en) * | 1967-04-25 | 1968-04-12 | Curtis Helene Ind Inc | Base for emulsion containing hydrogen peroxide |
| US3976223A (en) * | 1972-02-02 | 1976-08-24 | Carter-Wallace, Inc. | Aerosol package |
| US5104644A (en) * | 1990-02-07 | 1992-04-14 | 7-L Corporation | Mouthrinse composition |
| US5084268A (en) * | 1991-06-17 | 1992-01-28 | Dental Concepts, Inc. | Tooth whitening dentifrice |
-
1996
- 1996-09-20 EP EP96936055A patent/EP0862407A4/en not_active Withdrawn
- 1996-09-20 WO PCT/US1996/015596 patent/WO1997010802A1/en not_active Ceased
- 1996-09-20 CA CA 2232677 patent/CA2232677A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2232677A1 (en) | 1997-03-27 |
| EP0862407A4 (en) | 1999-03-03 |
| WO1997010802A1 (en) | 1997-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7060253B1 (en) | Topical formulations and delivery systems | |
| US5665332A (en) | System for delivering foams containing medicaments | |
| US6015547A (en) | Stable solution of zinc ions and bicarbonate and/or carbonate ions | |
| US6086856A (en) | System for delivering foamed oral hygiene compositions | |
| US10736825B2 (en) | Foaming skincare formulations | |
| EP2194959B1 (en) | Foamable oral care composition | |
| JP2003012511A (en) | Aerosol composition | |
| US20040197270A1 (en) | Topical formulations and delivery systems | |
| EP3454826B1 (en) | Whipped gel formulations | |
| US7851423B2 (en) | Post-foaming cleansing product with molecular oxygen | |
| EP0862407A1 (en) | Topical formulations and delivery systems | |
| AU1914800A (en) | Topical compositions including deodorant compositions | |
| CN102088947B (en) | Based on compositions and the application thereof of polymer/hydrogen peroxide complexes | |
| JP2003081812A (en) | Aerosol formulation | |
| JPH11279522A (en) | Preparation of gel-like product | |
| Klepak et al. | Antiperspirants and deodorants | |
| JP2003119109A (en) | Aerosol composition | |
| JP3494471B2 (en) | Aerosol composition for skin care | |
| JPH1149665A (en) | Anti-inflammatory/analgesic composition and aerosol product using the same | |
| CA3133720A1 (en) | Mousse products, methods and devices | |
| Nussinovitch | Cosmetics | |
| US20040018158A1 (en) | Topical compositions including sunscreen compositions | |
| HK40006476B (en) | Whipped gel formulations | |
| HK40006476A (en) | Whipped gel formulations | |
| WO1995005799A1 (en) | Deodorant composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19980422 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| A4 | Supplementary search report drawn up and despatched | ||
| AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
| 18W | Application withdrawn |
Withdrawal date: 19990401 |